What to know about a controversial new study on fluoride and IQ
Critics of a new study on water fluoridation and IQ are questioning its data and methodology.
Related Articles
Where are the personal journals from the early days of HIV?
For years, John Fleischman carried the journal of his late mentor, who died from HIV/AIDS. He finally found the perfect home for it at the…
Search Cancer Clinical Trials | OSUCCC – James
Search open enrollments clinical trials at the OSUCCC – James. Find out the study’s criteria, whether you may be eligible and more here.
Where are the personal journals from the early days of HIV?
For years, John Fleischman carried the journal of his late mentor, who died from HIV/AIDS. He finally found the perfect home for it at the…
E10: Healthcare and Parenthood: Facing Infertility in a Demanding Career(W/Dr Ariela Marshall, MD)
In this conversation, Dr. Ariela Marshall joins host Dr. Saba Fatima to discuss the often-overlooked issue of infertility among women physicians, sharing her…
Screening for Iron Deficiency Could Benefit Many Women Who Might Go Undiagnosed
Blood tests to detect low iron levels may be a cost-effective way to diagnose and treat iron deficiency, a new study shows.
BLOG: Three women in oncology on running the inaugural Every Woman’s Marathon
On Nov. 16, 2024, more than 7,000 runners convened in Savannah, Georgia, for the inaugural Every Woman’s Marathon.While billed as the Every Woman’s Marathon, it…
Andexanet alfa: trials just leave us with more questions
ANNEXA-I, the first ever randomised controlled trial of a reversal agent for direct oral anticoagulants, was published in 2024. The trial, which randomised patients with…
Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study
PURPOSEDatopotamab deruxtecan (Dato-DXd) is a trophoblast cell-surface antigen-2–directed antibody-drug conjugate with a highly potent topoisomerase I inhibitor payload. The TROPION-Lung05 phase II trial (ClinicalTrials.gov identifier:…
What does Medicaid look like in a second Trump presidency?
This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.
